Tapping Charles R, Crew Jeremy, Proteroe Andrew, Boardman Phil
Department of Radiology, Churchill Hospital, Headington, Oxford, UK.
Department of Urology, Churchill Hospital, Headington, Oxford, UK.
Acta Radiol Open. 2019 Jun 12;8(6):2058460119846061. doi: 10.1177/2058460119846061. eCollection 2019 Jun.
Prostate artery embolization (PAE) has been shown to be beneficial in treating men with benign prostatic hypertrophy (BPH). Here we describe treating four patients with prostate cancer (two with organ-confined and two with metastatic prostate cancer) with prostatic bleeding with PAE. Patients had other causes of hematuria excluded and were followed up at 3, 12, and 18 months after PAE. All four cases were technically successful and all cases of hematuria had resolved by the three-month follow-up (100%). There was one case of recurrence at 13 months after PAE which was successfully treated. PAE is useful for controlling significant prostatic bleeding in patients with prostate cancer and improves quality of life. Patients may, however, need repeated treatments to control the bleeding.
前列腺动脉栓塞术（PAE）已被证明对治疗良性前列腺增生（BPH）男性有益。在此，我们描述了用PAE治疗4例前列腺癌患者（2例为局限性前列腺癌，2例为转移性前列腺癌）的前列腺出血情况。排除了患者血尿的其他病因，并在PAE术后3个月、12个月和18个月进行随访。所有4例手术均技术成功，所有血尿病例在3个月随访时均已消退（100%）。PAE术后13个月有1例复发，经成功治疗。PAE对控制前列腺癌患者的严重前列腺出血有用，并可改善生活质量。然而，患者可能需要重复治疗以控制出血。
